By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech Release: Follow-Up Study Of Viaskin Peanut Shows Significant Increase In Peanut Consumption And Treatment Benefit In Peanut Allergic Children 10/5/2015 9:43:22 AM
DBV Tech Reports Interim Financial Results For The First Half Of 2015 7/27/2015 1:56:06 PM
DBV Tech: Announces Closing of $281.5 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares 7/21/2015 1:58:28 PM
DBV Tech Announces European Medicines Agency Paediatric Committee (PDCO) Positive Opinion On The Paediatric Investigation Plan For Viaskin Peanut For The Treatment Of Peanut Allergic Children 6/4/2015 9:28:38 AM
DBV Tech Nabs FDA Breakthrough Status for Peanut Allergy Patch 4/10/2015 6:10:06 AM
DBV Technologies Reports Full Year 2014 Financial Results 3/25/2015 7:44:48 AM
DBV Technologies Appoints Daniel Soland To Board Of Directors 3/10/2015 7:58:24 AM
DBV Technologies To Present At Upcoming Investor Conferences 3/6/2015 10:21:23 AM
DBV Technologies Release: Viaskin Data Presented At American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting Show Safety And Efficacy In The Treatment Of Food Allergies 2/24/2015 10:22:02 AM
DBV Technologies Welcomes Dr. J-P Moreau To Its Scientific Advisory Board 2/13/2015 7:46:53 AM